Oxford BioDynamics Statistics
Total Valuation
OXBOF has a market cap or net worth of 18.12 million. The enterprise value is 23.19 million.
| Market Cap | 18.12M |
| Enterprise Value | 23.19M |
Important Dates
The next estimated earnings date is Friday, February 27, 2026.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 4.29B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +442.40% |
| Shares Change (QoQ) | +126.07% |
| Owned by Insiders (%) | 1.44% |
| Owned by Institutions (%) | 67.27% |
| Float | 3.07B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.31 |
| PB Ratio | 12.08 |
| P/TBV Ratio | 1,348.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.55 |
| EV / Sales | 15.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.27 |
Financial Position
The company has a current ratio of 0.88, with a Debt / Equity ratio of 4.58.
| Current Ratio | 0.88 |
| Quick Ratio | 0.76 |
| Debt / Equity | 4.58 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.67 |
| Interest Coverage | -34.78 |
Financial Efficiency
Return on equity (ROE) is -407.49% and return on invested capital (ROIC) is -82.29%.
| Return on Equity (ROE) | -407.49% |
| Return on Assets (ROA) | -66.52% |
| Return on Invested Capital (ROIC) | -82.29% |
| Return on Capital Employed (ROCE) | -196.11% |
| Weighted Average Cost of Capital (WACC) | 2.38% |
| Revenue Per Employee | 35,900 |
| Profits Per Employee | -365,654 |
| Employee Count | 41 |
| Asset Turnover | 0.11 |
| Inventory Turnover | 2.22 |
Taxes
| Income Tax | -361,588 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.00% in the last 52 weeks. The beta is -0.50, so OXBOF's price volatility has been lower than the market average.
| Beta (5Y) | -0.50 |
| 52-Week Price Change | -80.00% |
| 50-Day Moving Average | 0.11 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 37.73 |
| Average Volume (20 Days) | 208,831 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OXBOF had revenue of 1.47 million and -14.99 million in losses. Loss per share was -0.01.
| Revenue | 1.47M |
| Gross Profit | 701,669 |
| Operating Income | -14.45M |
| Pretax Income | -15.35M |
| Net Income | -14.99M |
| EBITDA | -13.80M |
| EBIT | -14.45M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 1.87 million in cash and 6.87 million in debt, with a net cash position of -5.00 million.
| Cash & Cash Equivalents | 1.87M |
| Total Debt | 6.87M |
| Net Cash | -5.00M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.50M |
| Book Value Per Share | 0.00 |
| Working Capital | -436,863 |
Cash Flow
In the last 12 months, operating cash flow was -10.18 million and capital expenditures -22,851, giving a free cash flow of -10.20 million.
| Operating Cash Flow | -10.18M |
| Capital Expenditures | -22,851 |
| Free Cash Flow | -10.20M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 47.67% |
| Operating Margin | -981.46% |
| Pretax Margin | -1,043.10% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OXBOF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -442.40% |
| Shareholder Yield | -442.40% |
| Earnings Yield | -82.74% |
| FCF Yield | -56.31% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OXBOF has an Altman Z-Score of -12.68 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.68 |
| Piotroski F-Score | 2 |